Response of refractory osteosarcoma to thalidomide and celecoxib

Lancet Oncol. 2005 Dec;6(12):997-9. doi: 10.1016/S1470-2045(05)70468-X.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / pathology*
  • Celecoxib
  • Drug Resistance, Neoplasm
  • Drug Therapy, Combination
  • Hip / pathology
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Osteosarcoma / drug therapy*
  • Osteosarcoma / pathology*
  • Pyrazoles / therapeutic use*
  • Sulfonamides / therapeutic use*
  • Thalidomide / therapeutic use*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunosuppressive Agents
  • Pyrazoles
  • Sulfonamides
  • Thalidomide
  • Celecoxib